PARIS (Reuters) - Sanofi's experimental diabetes treatment Lyxumia can slow down the rate at which food passes and can reduce blood sugar levels after a meal when given in combination with other diabetes drugs, the drugmaker said in a statement on Tuesday.The data from late-stage studies was presented at the European Association for the Study of Diabetes (EASD) congress in Berlin.(Reporting by Elena Berton; Editing by James Regan)	1	2	2	2	2	2	1	1	1	2	2	1	1	1	2	4